Wealthstreet Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Wealthstreet Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19,800	Closed	-$294K	–	347
2019 Q2	$294K	Sell	19,800 -9,750	-33%	-$176K	0.04%	282
2019 Q1	$733K	Hold	29,550	–	–	0.1%	175
2018 Q4	$730K	Sell	29,550 -2,350	-7%	-$48K	0.1%	169
2018 Q3	$937K	Sell	31,900 -13,130	-29%	-$508K	0.12%	161
2018 Q2	$2.05M	Sell	45,030 -3,700	-8%	-$180K	0.27%	92
2018 Q1	$2.57M	Buy	48,730 +1,750	+4%	+$102K	0.32%	76
2017 Q4	$3.19M	Buy	+46,980	New	+$3.28M	0.39%	66

Other funds holding CLVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Wealthstreet Investment Advisors's CLVS Position: Q3 2019 in Review

Wealthstreet Investment Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 19,800 shares — an estimated $294K sold.

Wealthstreet Investment Advisors first reported a position in CLVS in Q4 2017 and held it in 7 quarters. The position peaked at $3.19M in Q4 2017. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

Wealthstreet Investment Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
Wealthstreet Investment Advisors sold 19,800 Clovis Oncology, Inc. shares in Q3 2019, an estimated $294K.
Wealthstreet Investment Advisors first reported a position in Clovis Oncology, Inc. in Q4 2017 and held it in 7 quarters.
Wealthstreet Investment Advisors's Clovis Oncology, Inc. position peaked at $3.19M in Q4 2017.
153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Wealthstreet Investment Advisors's 13F filing for Q3 2019, filed 31 Oct 2019.